Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2009
06/11/2009US20090149501 administering [7-(benzyloxy)-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone to mammals as analgesics, antiinflammatory agents and as neuroprotectants
06/11/2009US20090149500 solid forms of lenalidomide, treating cancer, inflammatory disease, myelodysplastic syndrome, undesired angiogenesis
06/11/2009US20090149499 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione)
06/11/2009US20090149498 Pharmaceutical composition having prokinetic effect
06/11/2009US20090149497 Polymorphs of fexofenadine hydrochloride
06/11/2009US20090149496 Inhibitors of the task-1 and task-3 ion channel
06/11/2009US20090149495 Compounds
06/11/2009US20090149494 THERAPEUTIC USE OF IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES
06/11/2009US20090149493 Inhibitors of the interaction between mdm2 and p53
06/11/2009US20090149492 3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-7,8-dihydro-1,6-naphthyridin-5(6H)-one, used as antidiabetic agents
06/11/2009US20090149491 Carbocyclic oxime hepatitis c virus serine protease inhibitors
06/11/2009US20090149490 Spermicidal and/or antifungal composition and methods of using the same
06/11/2009US20090149488 Tetrahydroprotoberberine Compounds, the Synthetic Method and the Use Thereof
06/11/2009US20090149487 4,5-diphenyl-pyrimidinylamino substituted carboxylic acids, method for the production and use thereof as medicaments
06/11/2009US20090149486 4,5-diphenyl-pyrimidinyl-oxy or -mercapto substituted carboxylic acids, method for the production and use thereof as medicaments
06/11/2009US20090149485 Pyrimidinediones as tyrosine kinase inhibitors
06/11/2009US20090149484 Quinazolin-4-one derivatives, process for their preparation and pharmaceutical compositions containing them
06/11/2009US20090149483 Bicyclic pyrrole derivatives
06/11/2009US20090149482 Stereochemically defined dipeptide esters of antiviral agents for enhanced ocular treatment
06/11/2009US20090149481 Pharmaceutical composition and beverage composition comprising l-arginine
06/11/2009US20090149480 Methods of using pde v inhibitors for the treatment of congestive heart failure
06/11/2009US20090149479 Dosing regimen
06/11/2009US20090149478 Novel combination anticancer agents
06/11/2009US20090149477 use for lowering blood glucose, treating diabetes, or increasing insulin release; 7-(4,5-Diphenylpyrimidin-2-yl)-6-heptynoic Acid
06/11/2009US20090149476 3-[[6-[4-(1,2,3,4-tetrahydro-1,8-naphthyridin-7-yl)-1-piperidinyl]-2,5-dimethyl-4-pyrimidinyl]amino]-N-[(phenylmethoxy)carbonyl]alanine, used for the treatment of osteoporosis, restenosis, arteriosclerosis, nephropathy or retinopathy
06/11/2009US20090149475 Thioxanthine Derivatives and Their Use as Inhibitors of MPO
06/11/2009US20090149474 tert-butyl 4-[(4-chlorobenzoyl)amino]-2-(dimethylamino)-1-phenyl-1H-imidazole-5-carboxylate, used for the treatment of gastrointestinal disorders such as gastroesophageal reflux, irritable bowel syndrome, dyspepsia, diarrhea and for the inhibition of transient lower esophageal sphincter relaxations
06/11/2009US20090149473 Topical antifungal composition
06/11/2009US20090149472 Salts of substitutted pyrazoline compounds, their preparation and use and medicaments
06/11/2009US20090149471 Monocyclic Heterocyclic Compounds
06/11/2009US20090149470 aurora kinase inhibitors; 2-(thiazol-2-ylamino)pyridine compounds as antitumor agents; 6-((4-(3-chloro-2-fluorobenzoyl)piperazin-1-yl)methyl)-N-thiazol-2-ylpyridin-2-amine for example
06/11/2009US20090149469 Phenyl-[4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yl]-amine derivatives as igf-ir inhibitors
06/11/2009US20090149468 Substituted heterocyclic compounds and methods of use
06/11/2009US20090149467 Tyrosine Kinase Inhibitors
06/11/2009US20090149466 Inhibitors of stearoyl-coa desaturase
06/11/2009US20090149465 Aminotetralin compounds as mu opioid receptor antagonists
06/11/2009US20090149464 Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases
06/11/2009US20090149463 Therapeutic agents
06/11/2009US20090149462 Process for purification of aprepitant
06/11/2009US20090149461 Method of treating cancer
06/11/2009US20090149460 New Compounds
06/11/2009US20090149459 P38 inhibitors and methods of use thereof
06/11/2009US20090149458 PYRROLO[3,2-d]PYRIMIDINE COMPOUNDS AND THEIR USE AS PI3 KINASE AND mTOR KINASE INHIBITORS
06/11/2009US20090149457 1H-Thieno[2,3-c]Pyrazole Compounds Useful as Kinase Inhibitors
06/11/2009US20090149456 2-Pyrimidinyl Pyrazolopyridine ErbB Kinase Inhibitors
06/11/2009US20090149454 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-(5 -methyl-3-isoxazolyl)-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide; for prophylaxis and treatment of diseases, such as VEGF mediated diseases; cancer
06/11/2009US20090149453 Methods and compositions for treating bacterial infections and diseases associated therewith
06/11/2009US20090149452 Xanthine oxidase inhibitor
06/11/2009US20090149451 Pharmaceutical formulations of potassium atp channel openers and uses thereof
06/11/2009US20090149450 Substituted imidazoheterocycles
06/11/2009US20090149449 Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto
06/11/2009US20090149448 Phenoxyacetic Acid Derivatives Useful for Treating Respiratory Diseases
06/11/2009US20090149447 Novel M3 Muscarinic Acetylcholine Receptor Antagonists
06/11/2009US20090149446 Compositions Comprising Nicotinic Agonists and Methods of Using Same
06/11/2009US20090149445 Tricyclic steroid hormone nuclear receptor modulators
06/11/2009US20090149444 Benzylamine analogues
06/11/2009US20090149443 P38 inhibitors and methods of use thereof
06/11/2009US20090149442 Atypical antipsychotic agents having low affinity for the D2 receptor
06/11/2009US20090149441 DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDES, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS
06/11/2009US20090149440 1-(6-Amino-3,5-difluoropyridin-2-yl)-6-fluoro-7-(3-isopropylaminoazetidin-1-yl)-8-methyl-4-oxo-1,4-dihydroquinolin-3-carboxylic acid; antibacterial agent; low toxicity, improved bioavailability, and low binding rate to serum proteins
06/11/2009US20090149439 Pyridylmethysulfone derivative
06/11/2009US20090149438 Pyrimidines as PLK inhibitors
06/11/2009US20090149437 Thieno-pyridine derivatives as mek inhibitors
06/11/2009US20090149436 Caspase inhibitor
06/11/2009US20090149435 Process for making a pharmaceutical composition
06/11/2009US20090149434 Formulations with improved bioavailability, comprising a steroid derivative and a polyglycolysed glyceride
06/11/2009US20090149433 Compositions for the treatment of inflammation of the gastrointestinal tract
06/11/2009US20090149432 Methods for administering corticosteroid formulations
06/11/2009US20090149431 Eplerenone Drug Substance Having High Phase Purity
06/11/2009US20090149430 Composition containing amidine derivatives or carboxamide derivatives and steroids, as a medicament
06/11/2009US20090149429 Antiviral compounds
06/11/2009US20090149428 Methods for Assessing the Predisposition or Susceptibility to COPD
06/11/2009US20090149427 Pharmaceutically acceptable salts and hydrates of risedronic acid
06/11/2009US20090149425 Malononitrile compound as pesticides
06/11/2009US20090149424 Heparin conjugates and methods
06/11/2009US20090149423 Use for a very low molecular weight heparins
06/11/2009US20090149422 Hemostatic material
06/11/2009US20090149421 Gel formation of polyelectrolyte aqueous solutions by thermally induced changes in ionization state
06/11/2009US20090149420 Novel compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders
06/11/2009US20090149419 Hydrazido derivatives of hyaluronic acid
06/11/2009US20090149418 Antimicrobial preparations using polysaccharide gel from durian fruit-rind
06/11/2009US20090149417 Methods and compositions for the treatment of cancer using benzopyrone-type PARP inhibitors
06/11/2009US20090149416 2' and 3'-Substituted Cyclobutyl Nucleoside Analogs for the Treatment Viral Infections and Abnormal Cellular Proliferation
06/11/2009US20090149415 Compounds for modulating the glycolysis enzyme complex and/or the transaminase complex
06/11/2009US20090149414 rAAV EXPRESSION SYSTEMS AND COMPOSITIONS
06/11/2009US20090149413 RORS as Modifiers of the p21 Pathway and Methods of Use
06/11/2009US20090149412 Method for Inhibition of Phospholamban Activity for the Treatment of Cardiac Disease and Heart Failure
06/11/2009US20090149410 Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease
06/11/2009US20090149409 Tetracycline-Regulated Adeno-Associated Viral (AAV) Vectors for Gene Delivery to the Nervous System
06/11/2009US20090149408 nucleotide sequence complementary to a target RNA sequence and a second sequence chemically modified so it can no longer act as a guide sequence for mediating RNA interference, having complementarity to said first sequence; inflammatory, respiratory, proliferative, autoimmune, cardiovascular diseases
06/11/2009US20090149407 RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA)
06/11/2009US20090149406 Plasmid PXL3179 or NV1FGF
06/11/2009US20090149405 Virus-like particle containing a Dengue virus recombinant replicon
06/11/2009US20090149404 Oligonucleotide analogues and methods utilizing the same
06/11/2009US20090149403 siRNA silencing of genes expressed in cancer
06/11/2009US20090149402 Pharmaceutical composition for treating cancer or diabetes
06/11/2009US20090149401 Amide and peptide derivatives of tetraalkylenepentamines as transfection agents
06/11/2009US20090149400 Anti-proliferative compounds, compositions, and methods of use thereof
06/11/2009US20090149399 Heterocyclic kinase inhibitors
06/11/2009US20090149398 6,11-3c-bicyclic 8a-azalide derivatives
1 ... 2698 2699 2700 2701 2702 2703 2704 2705 2706 2707 2708 2709 2710 2711 2712 2713 2714 2715 2716 2717 2718 ... 7860